BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6495747)

  • 21. Is the gastrin response to secretin provocation a function of antral G-cell mass? Results in the hypergastrinemia of acid hyposecretion.
    Brady CE; Hyatt JR; Utts SJ
    J Clin Gastroenterol; 1989 Feb; 11(1):27-32. PubMed ID: 2921489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reliable method for generating antibodies against pancreozymin, secretin and gastrin.
    Schlegel W; Raptis S
    Clin Chim Acta; 1976 Dec; 73(3):439-44. PubMed ID: 1000862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide characterization of secretin preparations.
    Wolfe MM; Howard JE; Kolts BE; McGuigan JE
    Dig Dis Sci; 1986 Mar; 31(3):257-64. PubMed ID: 2868851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum gastrin and its response to secretin in hyperparathyroid patients.
    Selking O; Johansson H; Lundqvist G
    Acta Chir Scand; 1981; 147(8):649-55. PubMed ID: 7344385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of secretin on gastric parietal cell ultrastructure in man.
    Tarnawski A; Ivey KJ; Krause WJ; Stachura J; McGuigan JE; Kolts BE; Sherman D; Burks M
    Lab Invest; 1982 Jan; 46(1):33-8. PubMed ID: 7033660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effects of gastrin, cholecystokinin-pancreozymin, secretin, and glucagon on human stomach muscle in vitro.
    Cameron AJ; Phillips SF; Summerskill WH
    Gastroenterology; 1970 Oct; 59(4):539-45. PubMed ID: 5477749
    [No Abstract]   [Full Text] [Related]  

  • 28. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the blood gas concentration caused by secretin and cholecystokinin. Indication of a vasomotor effect?
    Bauer FE; von Kleist D; Janisch HD; Hampel KE
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 1):263-6. PubMed ID: 3016071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of histamine-H2 receptor antagonists on serum gastrin levels in swine.
    Zavy MT; Hedde RD
    Lab Anim Sci; 1991 Oct; 41(5):456-61. PubMed ID: 1686922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy and precision of serum gastrin measurements in commercial laboratories.
    Notar-Francesco V; Samuel S; Kanakamedala S; Straus EW
    J Assoc Acad Minor Phys; 1995; 6(4):130-3. PubMed ID: 8520176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays.
    Jansen JB; Lamers CB
    Surgery; 1984 Jul; 96(1):55-60. PubMed ID: 6740496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of GRF with or without a SRIF antiserum on GH, IGF-1, thyroxin, cholecystokinin, gastrin and metabolite concentrations in growing rats.
    Dubreuil P; Brazeau P; Morisset J
    Growth Regul; 1994 Jun; 4(2):56-62. PubMed ID: 7950903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin.
    Cohen S; Lipshutz W
    J Clin Invest; 1971 Feb; 50(2):449-54. PubMed ID: 5540178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of secretin on release of heterogeneous forms of gastrin.
    Straus E; Greenstein AJ; Yalow RS
    Gut; 1975 Dec; 16(12):999-1005. PubMed ID: 1218824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogeny of the cholecystokinin/gastrin family.
    Johnsen AH
    Front Neuroendocrinol; 1998 Apr; 19(2):73-99. PubMed ID: 9578981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrin and cholecystokinin of the bullfrog, Rana catesbeiana, have distinct effects on gallbladder motility and gastric acid secretion in vitro.
    Nielsen KG; Bomgren P; Holmgren S; Johnsen AH
    Gen Comp Endocrinol; 1998 Nov; 112(2):247-54. PubMed ID: 9784308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endoscopy of the upper gastrointestinal tract: changes in the concentration of vasoactive intestinal polypeptide and gastrin?].
    Bauer FE; Schulz E; Janisch HD; von Kleist D; Hampel KE
    Wien Med Wochenschr; 1984 Aug; 134(15-16):355-9. PubMed ID: 6495748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.